Patent · US Active

Substituted anilines as CCR(4) antagonists

US10407417B2 · kind B2 · utility

3Cited by

3References

12Claims

0Family size

Assignee

CHEMOCENTRYX, INC. · US

Inventors

Trevor T. Charvat · San Jose, US
Junfa Fan · Palo Alto, US
Christopher W. Lange · Hayward, US
Manmohan Reddy Leleti · Sunnyvale, US
Yandong Li · San Jose, US
Venkat Reddy Mali · Cupertino, US
Jeffrey P. McMahon · San Francisco, US
Jay P. Powers · Pacifica, US
Sreenivas Punna · Sunnyvale, US
Ju Yang · Palo Alto, US

Key dates

Filing date	Aug 10, 2017
Grant date	Sep 10, 2019
Priority date	—
Expiry date	Aug 10, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Aniline compounds are provided which bind to CCR(4) and are useful for the treatment of diseases such as allergic diseases, autoimmune diseases, graft rejection and cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.